← Back to All Filings

Edwards Lifesciences SVP, Corporate Controller Disposes Shares

Low SignificanceAugust 31, 2026 at 10:07:16 PM UTC

Edwards Lifesciences Corp

$EW4CIK: 0001099800

Subscribe to track EW

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

📊 Insider Sale Alert: Edwards Lifesciences Corp ($EW) Insider: Andrew M. Dahl (SVP, Corporate Controller) Transaction: Sold 544 shares @ $91.06 Total Value: $49,533.92 Remaining Holdings: 14,868.41 shares (Direct) Significance: Low

Comprehensive Analysis

Executive Summary

On August 31, 2026, Andrew M. Dahl, SVP and Corporate Controller of Edwards Lifesciences Corp ($EW), reported the open market sale of 544 shares of common stock at an average price of $91.055 per share. The transaction totaled approximately $49,533.92.

Transaction Details

  • Security: Common Stock
  • Transaction Type: Open Market Sale (Code S)
  • Shares Sold: 544
  • Price Per Share: $91.055
  • Gross Proceeds: $49,533.92
  • Post-Transaction Holdings: 14,868.41 shares (Direct ownership)

Market & Portfolio Context

This sale represents roughly 3.5% of Mr. Dahl's reported direct equity stake prior to the transaction. Given the modest transaction size and the retention of over 14,800 shares, the transaction has Low trading significance and appears routine in nature.

Topics:#EdwardsLifesciences#EW#InsiderTrading#Form4#StockMarket

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.

The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.

Always do your own due diligence and consult a licensed professional.